2cureX Financial Statements From 2010 to 2026
| 2CUREX Stock | 0.54 0.03 5.88% |
Check 2cureX AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2cureX AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . 2cureX financial statements analysis is a perfect complement when working with 2cureX AB Valuation or Volatility modules.
2cureX |
2cureX AB Company Shares Outstanding Analysis
2cureX AB's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current 2cureX AB Shares Outstanding | 17.6 M |
Most of 2cureX AB's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 2cureX AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, 2cureX AB has 17.6 M of shares currently outstending. This is much higher than that of the sector and significantly higher than that of the Shares Outstanding industry. The shares outstanding for all Sweden stocks is notably lower than that of the firm.
2cureX AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 2cureX AB's current stock value. Our valuation model uses many indicators to compare 2cureX AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 2cureX AB competition to find correlations between indicators driving 2cureX AB's intrinsic value. More Info.2cureX AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value 2cureX AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for 2cureX AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About 2cureX AB Financial Statements
2cureX AB stakeholders use historical fundamental indicators, such as 2cureX AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although 2cureX AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in 2cureX AB's assets and liabilities are reflected in the revenues and expenses on 2cureX AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 2cureX AB. Please read more on our technical analysis and fundamental analysis pages.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in 2cureX Stock
2cureX AB financial ratios help investors to determine whether 2cureX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 2cureX with respect to the benefits of owning 2cureX AB security.